Telaprevir is a potential drug for repurposing against SARS-CoV-2: computational and in vitro studies

Telaprevir is a potential drug for repurposing against SARS-CoV-2: computational and in vitro studies

Drug repurposing is an important approach to the assignment of already approved drugs for new indications. This technique bypasses some steps in the traditional drug approval system, which saves time and lives in the case of pandemics. Direct acting antivirals (DAAs) have repeatedly repurposed from...

Full description

Bibliographic Details
Main Authors: Amal Mahmoud, Ahmed Mostafa, Ahmed A. Al-Karmalawy, Ahmad Zidan, Hamada S. Abulkhair, Sara H. Mahmoud, Mahmoud Shehata, Mahmoud M. Elhefnawi, Mohamed A. Ali
Format: Article
Language:English
Published: Elsevier 2021-09-01
Series:Heliyon
Subjects:
Anti-HCV
Drug repurposing
Telaprevir
Protease inhibitor
SARS-CoV-2
Online Access:http://www.sciencedirect.com/science/article/pii/S240584402102065X

Internet

http://www.sciencedirect.com/science/article/pii/S240584402102065X

Similar Items